Davis's Drug Guide
ombitasvir/paritaprevir/ritonavir
General
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
om-bit-as-vir/par-i-ta-pre-vir/ri-toe-na-vir
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Technivie
Ther. Class.
Pharm. Class.
NS5 inhibitors
protease inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Ombitasvir/paritaprevir/ritonavir." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110370/all/ombitasvir_paritaprevir_ritonavir.
Vallerand AHA, Sanoski CAC, Quiring CC. Ombitasvir/paritaprevir/ritonavir. Davis's Drug Guide. F.A. Davis Company; 2023. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110370/all/ombitasvir_paritaprevir_ritonavir. Accessed November 29, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Ombitasvir/paritaprevir/ritonavir. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110370/all/ombitasvir_paritaprevir_ritonavir
Vallerand AHA, Sanoski CAC, Quiring CC. Ombitasvir/paritaprevir/ritonavir [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 November 29]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110370/all/ombitasvir_paritaprevir_ritonavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - ombitasvir/paritaprevir/ritonavir
ID - 110370
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110370/all/ombitasvir_paritaprevir_ritonavir
PB - F.A. Davis Company
ET - 18
DB - Pediatrics Central
DP - Unbound Medicine
ER -
